Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
ClinicalTrials.gov study NCT00001496. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
ClinicalTrials.gov study NCT00176488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00593827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
ClinicalTrials.gov study NCT02774681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00633750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT00634088. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
ClinicalTrials.gov study NCT04084730. IPD Sharing: YES. Countries: 1. Publications: 0.
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
ClinicalTrials.gov study NCT00984399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib in Estrogen Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT01594216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study
ClinicalTrials.gov study NCT06922708. IPD Sharing: YES. Countries: 0. Publications: 14.
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
ClinicalTrials.gov study NCT01097460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01022138. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Re-expression of ER in Triple Negative Breast Cancers
ClinicalTrials.gov study NCT01194908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer
ClinicalTrials.gov study NCT04054986. IPD Sharing: YES. Countries: 1. Publications: 0.
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT02447328. IPD Sharing: YES. Countries: 1. Publications: 0.
Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
ClinicalTrials.gov study NCT03501693. IPD Sharing: NO. Countries: 1. Publications: 0.
Aurora: a Human-centered Program for Breast Cancer Patients in Chile, Easing Neoadjuvant Chemotherapy's Effects
ClinicalTrials.gov study NCT06449417. IPD Sharing: NO. Countries: 0. Publications: 4.
Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04345913. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT01953003. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy
ClinicalTrials.gov study NCT02761642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.